177 related articles for article (PubMed ID: 6788369)
1. Enhanced cytostatic effectiveness of aniline mustard against 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors during regression in response to ovariectomy.
Benckhuysen C; Ter Hart HG; Van Dijk PJ
Cancer Treat Rep; 1981; 65(7-8):567-74. PubMed ID: 6788369
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
Tsai TL; Katzenellenbogen BS
Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
[TBL] [Abstract][Full Text] [Related]
3. Effects of sequential and combined endocrine therapies on the growth of 7,12-dimethylbenz [alpha] anthracene-induced rat mammary carcinoma.
Iino Y; Ogawa T; Yoshida M; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1990 Sep; 20(3):259-62. PubMed ID: 2147726
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas.
Weckbecker G; Tolcsvai L; Stolz B; Pollak M; Bruns C
Cancer Res; 1994 Dec; 54(24):6334-7. PubMed ID: 7987824
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of aniline mustard glucuronide alone or in a combination with glucose in Walker cells in culture and sarcoma-180 tumour bearing animals.
Deliconstantinos G; Ramantanis G; Todorou DK
Biomed Pharmacother; 1983; 37(7):339-43. PubMed ID: 6667340
[TBL] [Abstract][Full Text] [Related]
6. Prenatal exposure to diethylstilbestrol: ovarian-independent growth of mammary tumors induced by 7,12-dimethylbenz[a]anthracene.
Boylan ES; Calhoon RE
J Natl Cancer Inst; 1981 Apr; 66(4):649-52. PubMed ID: 6785506
[TBL] [Abstract][Full Text] [Related]
7. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
[TBL] [Abstract][Full Text] [Related]
8. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
[TBL] [Abstract][Full Text] [Related]
9. Levels of cyclic nucleotides in autotransplanted 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors during their growth and regression.
Lee C
J Natl Cancer Inst; 1980 Nov; 65(5):1029-32. PubMed ID: 6253705
[TBL] [Abstract][Full Text] [Related]
10. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat.
Gandilhon P; Melancon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1982 Aug; 69(2):447-51. PubMed ID: 6287078
[TBL] [Abstract][Full Text] [Related]
12. Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors.
De Coster R; Van Ginckel RF; Callens MJ; Goeminne NK; Janssens BL
Cancer Res; 1992 Mar; 52(5):1240-4. PubMed ID: 1737385
[TBL] [Abstract][Full Text] [Related]
13. Origin of the increased activity of beta-glucuronidase in the soluble fraction of rat mammary tumors during ovariectomy-induced regression.
Beem EP; Hillebrand MJ; Benckhuijsen C; Overdijk B
Cancer Res; 1987 Aug; 47(15):3980-7. PubMed ID: 3607744
[TBL] [Abstract][Full Text] [Related]
14. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
15. Restraint-induced inhibition of 7,12-dimethylbenz[a]anthracene-induced mammary tumors: relation to stages of tumor development.
Newberry BH
J Natl Cancer Inst; 1978 Sep; 61(3):725-9. PubMed ID: 99522
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
Tanaka M; Yano S; Hasegawa Y; Nakao K
Arzneimittelforschung; 1994 Jun; 44(6):774-8. PubMed ID: 8053980
[TBL] [Abstract][Full Text] [Related]
17. Change in chemosensitivity of DMBA-induced rat mammary tumor after oophorectomy.
Isogai M; Kondo K; Kitamura N
Anticancer Res; 1998; 18(2A):963-6. PubMed ID: 9615747
[TBL] [Abstract][Full Text] [Related]
18. Hormone dependence of 7,12-dimethylbenz[a]anthracene-induced mammary tumor growth: correlation with prostaglandin E2 content.
Foecking MK; Kibbey WE; Abou-Issa H; Matthews RH; Minton JP
J Natl Cancer Inst; 1982 Aug; 69(2):443-6. PubMed ID: 6810004
[TBL] [Abstract][Full Text] [Related]
19. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC
Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843
[TBL] [Abstract][Full Text] [Related]
20. Effect of retinyl acetate on the occurrence of ovarian hormone-responsive and -nonresponsive mammary cancers in the rat.
Thompson HJ; Meeker LD; Tagliaferro AR; Becci PJ
Cancer Res; 1982 Mar; 42(3):903-5. PubMed ID: 6800647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
